David G Beer

Q: What Schools Are Affiliated With David G Beer

David G Beer is affiliated with the following schools: University of California, Berkeley, University of New South Wales, University of Michigan, Stanford University, University of Siena, Kagawa University

David G Beer's AcademicInfluence.com Rankings

David G Beer

Engineering

#7510

World Rank

#8886

Historical Rank

Electrical Engineering

#2353

World Rank

#2461

Historical Rank

engineering Degrees

David G Beer

Computer Science

#10224

World Rank

#10720

Historical Rank

Computational Linguistics

#2585

World Rank

#2610

Historical Rank

Machine Learning

#4683

World Rank

#4735

Historical Rank

Artificial Intelligence

#5045

World Rank

#5110

Historical Rank

computer-science Degrees

Download Badge

Engineering
Computer Science

David G Beer's Degrees

PhD Computer Science Stanford University
Masters Electrical Engineering University of California, Berkeley
Bachelors Computer Engineering University of California, Berkeley

Similar Degrees You Can Earn

Best Online PhD of Computer Science (Doctorates) 2026

Why Is David G Beer Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David G Beer's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Comprehensive molecular characterization of gastric adenocarcinoma (2014) (4496)
Comprehensive molecular profiling of lung adenocarcinoma (2014) (4095)
The landscape of somatic copy-number alteration across human cancers (2010) (3297)
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma (2011) (3193)
Comprehensive genomic characterization of squamous cell lung cancers (2012) (2998)
Somatic mutations affect key pathways in lung adenocarcinoma (2008) (2640)
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer (2016) (2632)
The landscape of long noncoding RNAs in the human transcriptome (2015) (2174)
Gene-expression profiles predict survival of patients with lung adenocarcinoma (2002) (1982)
Oncogenic Signaling Pathways in The Cancer Genome Atlas (2018) (1646)
Comprehensive Characterization of Cancer Driver Genes and Mutations (2018) (1360)
Characterizing the cancer genome in lung adenocarcinoma (2007) (1122)
Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study (2008) (1063)
Discordant Protein and mRNA Expression in Lung Adenocarcinomas * (2002) (922)
SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas (2009) (904)
Exome and whole genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity (2013) (700)
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. (2011) (600)
Pathogenic Germline Variants in 10,389 Adult Cancers (2018) (501)
Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer. (2011) (474)
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients (2018) (471)
Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. (2006) (425)
MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. (2009) (391)
Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. (2000) (380)
Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis-Prone Lung Cancers (2013) (362)
An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer (2001) (315)
Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. (2002) (307)
Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. (2000) (306)
Paired Exome Analysis of Barrett’s Esophagus and Adenocarcinoma (2015) (281)
Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk (2005) (270)
Protein profiles associated with survival in lung adenocarcinoma (2003) (265)
Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. (2012) (260)
EML4-ALK fusion lung cancer: a rare acquired event. (2008) (248)
Amplification and over‐expression of the EGFR and erbB‐2 genes in human esophageal adenocarcinomas (1993) (246)
A prognostic DNA methylation signature for stage I non-small-cell lung cancer. (2013) (236)
Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. (2001) (215)
Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. (2001) (212)
The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer (2016) (197)
Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context (2018) (188)
Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma. (2013) (184)
Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA (2017) (176)
Circular RNA circHIPK3 modulates autophagy via MIR124-3p-STAT3-PRKAA/AMPKα signaling in STK11 mutant lung cancer (2020) (175)
Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays. (2005) (173)
Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma (2006) (168)
Targeted Imaging of Esophageal Neoplasia with a Fluorescently Labeled Peptide: First-in-Human Results (2013) (162)
Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model (2014) (161)
The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification (2016) (152)
The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis. (2004) (151)
Prognostic Immune Markers in Non–Small Cell Lung Cancer (2011) (149)
Gene amplification in esophageal adenocarcinomas and Barrett's with high-grade dysplasia. (2003) (145)
Fas/APO-1 (CD95) is not translocated to the cell membrane in esophageal adenocarcinoma. (1997) (143)
The landscape of antisense gene expression in human cancers (2015) (139)
A novel amplicon at 8p22-23 results in overexpression of cathepsin B in esophageal adenocarcinoma. (1998) (133)
Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas. (2005) (128)
cAMP-response Element-binding Protein Mediates Acid-induced NADPH Oxidase NOX5-S Expression in Barrett Esophageal Adenocarcinoma Cells* (2006) (128)
Upregulated INHBA expression may promote cell proliferation and is associated with poor survival in lung adenocarcinoma. (2009) (127)
Verification and unmasking of widely used human esophageal adenocarcinoma cell lines. (2010) (127)
Epidermal Growth Factor Receptor Tyrosine Kinase Defines Critical Prognostic Genes of Stage I Lung Adenocarcinoma (2012) (126)
Development and Validation of a Scalable Next-Generation Sequencing System for Assessing Relevant Somatic Variants in Solid Tumors12 (2015) (126)
Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas (1997) (125)
Transcriptome Meta-Analysis of Lung Cancer Reveals Recurrent Aberrations in NRG1 and Hippo Pathway Genes (2014) (120)
RANTES expression is a predictor of survival in stage I lung adenocarcinoma. (2002) (115)
A Novel Serum 4-microRNA Signature for Lung Cancer Detection (2015) (115)
Reduced selenium‐binding protein 1 expression is associated with poor outcome in lung adenocarcinomas (2004) (114)
Comparative genomics of esophageal adenocarcinoma and squamous cell carcinoma. (2012) (111)
Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers. (2017) (109)
Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas (1999) (107)
Molecular characterization of FRAXB and comparative common fragile site instability in cancer cells (2002) (106)
The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification (2009) (104)
The Hepatocyte Nuclear Factor 3 α Gene, HNF3α (FOXA1), on Chromosome Band 14q13 Is Amplified and Overexpressed in Esophageal and Lung Adenocarcinomas (2002) (103)
CYP24A1 Is an Independent Prognostic Marker of Survival in Patients with Lung Adenocarcinoma (2010) (103)
Affinity peptide for targeted detection of dysplasia in Barrett's esophagus. (2010) (99)
Silencing of Long Noncoding RNA MIR22HG Triggers Cell Survival/Death Signaling via Oncogenes YBX1, MET, and p21 in Lung Cancer. (2018) (96)
Expression of the c-raf protooncogene, gamma-glutamyltranspeptidase, and gap junction protein in rat liver neoplasms. (1988) (96)
Overexpression of 5-Lipoxygenase in Rat and Human Esophageal Adenocarcinoma and Inhibitory Effects of Zileuton and Celecoxib on Carcinogenesis (2004) (96)
A MicroRNA Cluster at 14q32 Drives Aggressive Lung Adenocarcinoma (2014) (95)
Confirmation of Gene Expression–Based Prediction of Survival in Non–Small Cell Lung Cancer (2008) (95)
Curcumin promotes apoptosis, increases chemosensitivity, and inhibits nuclear factor kappaB in esophageal adenocarcinoma. (2010) (93)
Lack of cell surface Fas/APO-1 expression in pulmonary adenocarcinomas. (1998) (92)
The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas. (2002) (92)
E-cadherin expression in primary and metastatic thoracic neoplasms and in Barrett's oesophagus. (1995) (91)
Doubly Penalized Buckley–James Method for Survival Data with High‐Dimensional Covariates (2008) (90)
Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas (2003) (89)
Epithelial-mesenchymal transition leads to NK cell–mediated metastasis-specific immunosurveillance in lung cancer (2018) (88)
Overexpression of Oncoprotein 18 Correlates with Poor Differentiation in Lung Adenocarcinomas* (2003) (87)
Induction of altered hepatic foci in rats by the administration of hypolipidemic peroxisome proliferators alone or following a single dose of diethylnitrosamine. (1986) (87)
Amplification of chromosomal segment 4q12 in non-small cell lung cancer (2009) (87)
Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma. (2007) (87)
Hypermethylation of Tachykinin-1 Is a Potential Biomarker in Human Esophageal Cancer (2007) (84)
Activation of GATA binding protein 6 (GATA6) sustains oncogenic lineage-survival in esophageal adenocarcinoma (2012) (83)
Expression of H-ras and c-myc protooncogenes in isolated gamma-glutamyl transpeptidase-positive rat hepatocytes and in hepatocellular carcinomas induced by diethylnitrosamine. (1986) (81)
The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer (2016) (81)
KRAS-G12C Mutation Is Associated with Poor Outcome in Surgically Resected Lung Adenocarcinoma (2014) (80)
Accurate molecular classification of human cancers based on gene expression using a simple classifier with a pathological tree-based framework. (2003) (79)
An integrative approach to reveal driver gene fusions from paired-end sequencing data in cancer (2009) (79)
Indomethacin-induced apoptosis in esophageal adenocarcinoma cells involves upregulation of Bax and translocation of mitochondrial cytochrome C independent of COX-2 expression. (2000) (79)
Leukotriene A4 hydrolase in rat and human esophageal adenocarcinomas and inhibitory effects of bestatin. (2003) (79)
Hypermethylation of the AKAP12 Promoter is a Biomarker of Barrett's-Associated Esophageal Neoplastic Progression (2008) (78)
Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma. (2002) (77)
A minimal critical region of the 8p22-23 amplicon in esophageal adenocarcinomas defined using sequence tagged site-amplification mapping and quantitative polymerase chain reaction includes the GATA-4 gene. (2000) (76)
Time-resolved optical imaging provides a molecular snapshot of altered metabolic function in living human cancer cell models. (2006) (75)
Reconstructing targetable pathways in lung cancer by integrating diverse omics data (2013) (74)
A database of protein expression in lung cancer (2001) (73)
NADPH Oxidase NOX5-S Mediates Acid-induced Cyclooxygenase-2 Expression via Activation of NF-κBin Barrett's Esophageal Adenocarcinoma Cells* (2007) (72)
Specific Ki‐ras codon 61 mutations may determine the development of urethan‐induced mouse lung adenomas or adenocarcinomas (1990) (70)
A functional role for KLF6-SV1 in lung adenocarcinoma prognosis and chemotherapy response. (2008) (69)
The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region. (1998) (69)
KRAS protein stability is regulated through SMURF2: UBCH5 complex-mediated β-TrCP1 degradation. (2014) (67)
Growth arrest, apoptosis, and telomere shortening of Barrett's-associated adenocarcinoma cells by a telomerase inhibitor. (2004) (67)
Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis. (2014) (66)
Cisplatin Induces Bmi1 and Enhances the Stem Cell Fraction in Head and Neck Cancer (2015) (65)
Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomas. (1995) (64)
L-type amino acid transporter-1 overexpression and melphalan sensitivity in Barrett's adenocarcinoma. (2004) (64)
Decreased Selenium-Binding Protein 1 in Esophageal Adenocarcinoma Results from Posttranscriptional and Epigenetic Regulation and Affects Chemosensitivity (2010) (63)
Amplification and overexpression of the L-MYC proto-oncogene in ovarian carcinomas. (2003) (62)
Genetic influence on type 2 or Clara cell origin of pulmonary adenomas in urethan-treated mice. (1985) (62)
Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factors (2008) (62)
Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas. (1994) (61)
Correlation of PD‐L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early‐Stage Squamous Cell Lung Carcinoma (2019) (60)
Comparison of Cancer-Associated Genetic Abnormalities in Columnar-Lined Esophagus Tissues With and Without Goblet Cells (2014) (60)
An Embryonic Stem Cell–Like Signature Identifies Poorly Differentiated Lung Adenocarcinoma but not Squamous Cell Carcinoma (2009) (60)
Multimodal endoscope can quantify wide-field fluorescence detection of Barrett’s neoplasia (2015) (60)
Differential Tks5 isoform expression contributes to metastatic invasion of lung adenocarcinoma. (2013) (59)
Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer (2015) (59)
Expression and effect of inhibition of the ubiquitin-conjugating enzyme E2C on esophageal adenocarcinoma. (2006) (58)
Intestinal differentiation and p53 gene alterations in barrett's esophagus and esophageal adenocarcinoma (1994) (57)
INHBA Overexpression Promotes Cell Proliferation and May Be Epigenetically Regulated in Esophageal Adenocarcinoma (2009) (57)
Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas. (2003) (57)
Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon. (2000) (55)
Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma (2015) (55)
The vitamin D/CYP24A1 story in cancer. (2010) (55)
Characterization of vitamin D receptor (VDR) in lung adenocarcinoma. (2012) (55)
Epigenetic Inactivation of microRNA-34b/c Predicts Poor Disease-Free Survival in Early-Stage Lung Adenocarcinoma (2013) (54)
Mutations in the DDR 2 Kinase Gene identify a Novel therapeutic target in squamous cell lung cancer (2011) (53)
A Proteomic Approach to the Identification of Lung Cancer Markers (2002) (52)
Nuclear Localized Phosphorylated FADD Induces Cell Proliferation and is Associated with Aggressive Lung Cancer (2005) (52)
Detection of erbB-2 amplifications in tumors and sera from esophageal carcinoma patients. (1999) (51)
Clinically Relevant Characterization of Lung Adenocarcinoma Subtypes Based on Cellular Pathways: An International Validation Study (2010) (51)
Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma In vitro and In vivo (2008) (50)
Sequential 5-Aza 2′-deoxycytidine/depsipeptide FK228 treatment induces tissue factor pathway inhibitor 2 (TFPI-2) expression in cancer cells (2005) (50)
Overexpression of FAM83H-AS1 indicates poor patient survival and knockdown impairs cell proliferation and invasion via MET/EGFR signaling in lung cancer (2017) (48)
Anticancer Activity of a Broccoli Derivative, Sulforaphane, in Barrett Adenocarcinoma: Potential Use in Chemoprevention and as Adjuvant in Chemotherapy (2010) (48)
AZGP1 Autoantibody Predicts Survival and Histone Deacetylase Inhibitors Increase Expression in Lung Adenocarcinoma (2008) (48)
Pulmonary venous blood sampling significantly increases the yield of circulating tumor cells in early-stage lung cancer. (2016) (47)
Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomas (1998) (47)
Non-coding RNA LINC00857 is predictive of poor patient survival and promotes tumor progression via cell cycle regulation in lung cancer (2016) (47)
Sucrase-isomaltase gene expression in Barrett's esophagus and adenocarcinoma. (1993) (45)
Integrative Genomics Identified RFC3 As an Amplified Candidate Oncogene in Esophageal Adenocarcinoma (2012) (44)
Regulation of EGFR protein stability by the HECT-type ubiquitin ligase SMURF2. (2011) (43)
Anticancer activity of a broccoli derivative, sulforaphane, in barrett adenocarcinoma: potential use in chemoprevention and as adjuvant in chemotherapy. (2010) (40)
Translocation breakpoints in FHIT and FRA3B in both homologs of chromosome 3 in an esophageal adenocarcinoma (2001) (40)
Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer (2019) (39)
CHK1 levels correlate with sensitization to pemetrexed by CHK1 inhibitors in non-small cell lung cancer cells. (2013) (39)
Expression of albumin messenger RNA detected by in situ hybridization in preneoplastic and neoplastic lesions in rat liver. (1986) (38)
Epithelial-mesenchymal transition-associated secretory phenotype predicts survival in lung cancer patients. (2014) (37)
Stromal LRP1 in Lung Adenocarcinoma Predicts Clinical Outcome (2011) (37)
Phosphorylation of FADD by the kinase CK1α promotes KRASG12D-induced lung cancer (2015) (36)
Proteomic analysis of eIF‐5A in lung adenocarcinomas (2003) (36)
Telomere Maintenance in Laser Capture Microdissection–Purified Barrett's Adenocarcinoma Cells and Effect of Telomerase Inhibition In vivo (2008) (36)
Transforming properties of a Q18-->E mutation of the microtubule regulator Op18. (2002) (35)
Cigarette Smoke Mediates Epigenetic Repression of miR-217 During Esophageal Adenocarcinogenesis (2015) (35)
Expression Levels of Protein Kinase C-α in Non–Small-Cell Lung Cancer (2004) (34)
Melanoma-Associated Antigens in Esophageal Adenocarcinoma (2004) (34)
Diversity of the angiogenic phenotype in non-small cell lung cancer. (2007) (34)
Developmental changes in the endogenous Ca2+-stimulated proteolysis of mouse lung cAMP-dependent protein kinases. (1984) (34)
Ki‐ras activation and expression in transformed mouse lung cell lines (1990) (33)
Expression of the glucocorticoid receptor and K-ras genes in urethan-induced mouse lung tumors and transformed cell lines. (1991) (33)
STAT5 mediates PAF-induced NADPH oxidase NOX5-S expression in Barrett's esophageal adenocarcinoma cells. (2008) (32)
Biomarkers and molecular testing for early detection, diagnosis, and therapeutic prediction of lung cancer. (2013) (32)
Development and Validation of a Quantitative Real-Time Polymerase Chain Reaction Classifier for Lung Cancer Prognosis (2011) (32)
Biological markers characterizing the development of preneoplastic and neoplastic lesions in rodent liver. (1987) (31)
Genetic variation in the proliferation of murine pulmonary type II cells: basal rates and alterations following urethan treatment. (1986) (31)
Using second harmonic generation to predict patient outcome in solid tumors (2015) (30)
Melanoma-associated antigens in esophageal adenocarcinoma: identification of novel MAGE-A10 splice variants. (2004) (30)
Clinical models of chemoprevention for the esophagus. (1998) (29)
Autoradiographic localization of specific [3H]dexamethasone binding in fetal lung. (1984) (29)
Signaling pathway-based identification of extensive prognostic gene signatures for lung adenocarcinoma. (2012) (27)
Overexpression of LINC00152 correlates with poor patient survival and knockdown impairs cell proliferation in lung cancer (2017) (27)
Cytochromes P450 are expressed in proliferating cells in Barrett's metaplasia. (1999) (27)
The role of Dickkopf-3 overexpression in esophageal adenocarcinoma. (2015) (27)
Comparative Proteomics Analysis of Barrett Metaplasia and Esophageal Adenocarcinoma Using Two-dimensional Liquid Mass Mapping*S (2007) (27)
Gastrin stimulates receptor-mediated proliferation of human esophageal adenocarcinoma cells (2004) (26)
Identification of intestinal‐type Barrett's metaplasia by using the intestine‐specific protein villin and esophageal brush cytology (1999) (25)
Distal chromosome 17q loss in Barrett's esophageal and gastric cardia adenocarcinomas: Implications for tumorigenesis (1998) (25)
IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma (2015) (25)
Molecular Predictors of Prognosis in Lung Cancer (2012) (25)
Epigenetic Regulation of Vitamin D Metabolism in Human Lung Adenocarcinoma (2014) (24)
Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma (2017) (24)
Increased Variance in Oral and Gastric Microbiome Correlates With Esophagectomy Anastomotic Leak. (2018) (24)
Proto-oncogene activation during chemically induced hepatocarcinogenesis in rodents. (1989) (24)
Changes in cyclic adenosine 3':5'-monophosphate-dependent protein kinases during the progression of urethan-induced mouse lung tumors. (1985) (24)
Checkpoint kinase 1 protein expression indicates sensitization to therapy by checkpoint kinase 1 inhibition in non-small cell lung cancer. (2014) (23)
LINC00857 Interacting with YBX1 to Regulate Apoptosis and Autophagy via MET and Phosphor-AMPKa Signaling (2020) (23)
Signatures of Drug Sensitivity in Nonsmall Cell Lung Cancer (2011) (22)
Specific gene expression during compensatory renal hypertrophy in the rat (1987) (22)
Functional expression of TRAIL receptors TRAIL-R1 and TRAIL-R2 in esophageal adenocarcinoma. (2006) (21)
Expression levels of protein kinase C-alpha in non-small-cell lung cancer. (2004) (21)
Methods in laboratory investigation. Autoradiographic demonstration of the specific binding and nuclear localization of 3H-dexamethasone in adult mouse lung. (1983) (21)
Genomic regions associated with susceptibility to Barrett’s esophagus and esophageal adenocarcinoma in African Americans: The cross BETRNet admixture study (2017) (21)
TGM2: A Cell Surface Marker in Esophageal Adenocarcinomas (2014) (21)
Localization of specific [3H]dexamethasone binding in urethan-induced mouse lung tumors. (1984) (20)
Automated integration of monolith‐based protein separation with on‐plate digestion for mass spectrometric analysis of esophageal adenocarcinoma human epithelial samples (2006) (20)
MAP3K3 expression in tumor cells and tumor-infiltrating lymphocytes is correlated with favorable patient survival in lung cancer (2015) (20)
Oncogenic Potential of CYP24A1 in Lung Adenocarcinoma (2017) (19)
Induction of glutathione S‐transferase‐π in Barrett's metaplasia and Barrett's adenocarcinoma cell lines (1999) (19)
Multiplexed endoscopic imaging of Barrett’s neoplasia using targeted fluorescent heptapeptides in a phase 1 proof-of-concept study (2020) (19)
Multiple forms of genetic instability within a 2‐Mb chromosomal segment of 3q26.3–q27 are associated with development of esophageal adenocarcinoma (2006) (19)
Unique expression patterns and alterations in the intestinal protein villin in primary and metastatic pulmonary adenocarcinomas (1998) (19)
Altered trafficking of Fas and subsequent resistance to Fas-mediated apoptosis occurs by a wild-type p53 independent mechanism in esophageal adenocarcinoma. (2005) (18)
Telomerase Variant A279T Induces Telomere Dysfunction and Inhibits Non-Canonical Telomerase Activity in Esophageal Carcinomas (2014) (18)
Induction of Thioredoxin-Interacting Protein by a Histone Deacetylase Inhibitor, Entinostat, Is Associated with DNA Damage and Apoptosis in Esophageal Adenocarcinoma (2018) (17)
LINC00857 knockdown inhibits cell proliferation and induces apoptosis via involving STAT3 and MET oncogenic proteins in esophageal adenocarcinoma (2019) (17)
Immune determinants of Barrett's progression to esophageal adenocarcinoma. (2020) (17)
Gene expression patterns define pathways correlated with loss of differentiation in lung adenocarcinomas (2003) (17)
Use of Appropriate Surveillance for Patients With Nondysplastic Barrett’s Esophagus (2018) (16)
Functional changes in the regulatory subunit of the type II cyclic adenosine 3':5'-monophosphate-dependent protein kinase isozyme during normal and neoplastic lung development. (1984) (16)
Exisulind and CP248 induce growth inhibition and apoptosis in human esophageal adenocarcinoma and squamous carcinoma cells. (2003) (15)
Genomic and proteomic analyses of vascular endothelial growth factor and insulin-like growth factor-binding protein 3 in lung adenocarcinomas. (2004) (15)
A Predictive 7-Gene Assay and Prognostic Protein Biomarkers for Non-small Cell Lung Cancer (2018) (15)
Molecular biology, genomics, and proteomics in bronchioloalveolar carcinoma. (2006) (15)
MiR-22-3p suppresses cell growth via MET/STAT3 signaling in lung cancer. (2021) (13)
Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal Cells. (2019) (13)
in squamous cell lung cancer (2011) (13)
Multi-institutional prospective validation of prognostic mRNA signatures in early stage squamous lung cancer (Alliance). (2020) (13)
Detection of p53 nuclear protein accumulation in brushings and biopsies of Barrett's esophagus. (1997) (13)
Validation of a serum 4-microRNA signature for the detection of lung cancer. (2019) (12)
Identification and validation of FGFR2 peptide for detection of early Barrett's neoplasia (2017) (12)
18F-FDG PET intensity correlates with a hypoxic gene signature and other oncogenic abnormalities in operable non-small cell lung cancer (2018) (12)
Loss of glucocorticoid‐dependent growth inhibition in transformed mouse lung cells (1996) (12)
Sperm protein 17 is a novel marker for predicting cisplatin response in esophageal squamous cancer cell lines (2010) (12)
KRAS-G12C mutation is associated with poor outcome in surgically resected lung adenocarcinoma. (2015) (11)
Monoclonal antibodies specific for oncofetal antigen – immature laminin receptor protein: Effects on tumor growth and spread in two murine models (2015) (11)
Measurement of intracellular oxygen levels using fluorescence lifetime imaging microscopy (FLIM) (2005) (10)
Detection of Barrett's adenocarcinoma of the gastric cardia with sucrase isomaltase and p53. (1996) (10)
Identification of Tumor Specific Peptide as EpCAM Ligand and Its Potential Diagnostic and Therapeutic Clinical Application. (2019) (10)
Genomic similarity between gastroesophageal junction and esophageal Barrett's adenocarcinomas (2016) (10)
Effect of increased glucocorticoid responsiveness in transformed mouse lung cells (1995) (9)
Selective inhibition of cyclooxygenase-2 inhibits growth and induces apoptosis in human esophageal adenocarcinoma cells (2000) (9)
Constitutively Higher Level of GSTT2 in Esophageal Tissues From African Americans Protects Cells Against DNA Damage. (2019) (8)
Positron Emission Tomography 18F-Fluorodeoxyglucose Uptake Correlates with KRAS and EMT Gene Signatures in Operable Esophageal Adenocarcinoma. (2018) (8)
Finite proliferative lifespanin vitro of a human breast cancer cell strain isolated from a metastatic lymph node (1993) (8)
Transforming properties of a Q 18 → E mutation of the microtubule regulator Op 18 (2002) (8)
Ki‐ras mRNA regulation in untransformed mouse lung cells (1993) (7)
Inhibition of tumor necrosis factor production by lymphocytes from anti-TNF antibody-treated, cardiac-allografted rats. (1994) (6)
Altered dexamethasone responsiveness and loss of growth control in tumorigenic mouse lung cell lines (1993) (6)
Silencing of LOC389641 impairs cell proliferation and induces autophagy via EGFR/MET signaling in lung adenocarcinoma (2020) (6)
Protein Expression Analysis (2005) (6)
Hidden Markov model for defining genomic changes in lung cancer using gene expression data. (2006) (6)
Sensitive, quantitative, and high-throughput detection of angiogenic markers using shape-coded hydrogel microparticles. (2015) (6)
Barrett's Esophagus Translational Research Network (BETRNet): the pivotal role of multi-institutional collaboration in esophageal adenocarcinoma research. (2014) (5)
Detection of Barrett’s neoplasia with a near-infrared fluorescent heterodimeric peptide (2021) (5)
Squamous cell carcinomas and adenocarcinomas of the esophagus: One treatment does not rule them all. (2017) (5)
Collagen modifying enzyme P4HA1 is overexpressed and plays a role in lung adenocarcinoma (2021) (5)
CYP 24 A 1 Is an Independent Prognostic Marker of Survival in Patients with Lung Adenocarcinoma Running Title : CYP 24 A 1 Prognostic Marker in Lung Adenocarcinoma (2010) (5)
Altered Surface Markers in Lung Cancer (2003) (5)
DNA Methylation Changes in Lung Cancer (1998) (4)
Influence of the glucocorticoid receptor on c‐fos inducibility in activated ras‐containing mouse lung cells (1996) (4)
Gene expression during multistage hepatocarcinogenesis. (1988) (4)
Erratum: Phosphorylation of FADD by the kinase CK1α promotes KRASG12D induced lung cancer (Science Signaling 8:361 (ra9)) (2015) (4)
Altered surface markers in lung cancer. Lack of cell-surface Fas/APO-1 expression in pulmonary adenocarcinoma may allow escape from immune surveillance. (2003) (3)
Downregulation of miR-99 a / let-7 c / miR-125 b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma (2017) (3)
Phosphorylation of FADD by the kinase CK1 alpha promotes KRAS(G12D)-induced lung cancer (vol 8, er3, 2015) (2015) (3)
Proto-oncogene and gap-junction protein expression in rodent liver neoplasms. (1990) (3)
Chaperones and Ubiquitin Ligases Balance Mutant p53 Protein Stability in Esophageal and Other Digestive Cancers (2020) (3)
838 Risk Factors for Progression of Barrett's Esophagus With Low-Grade Dysplasia (2016) (3)
Detection of erbB2 Amplifications in Tumors and Sera from Esophageal Carcinoma Patients 1 (1999) (2)
The cytochrome P450 enzyme CYP24A1 increases proliferation of mutant KRAS-dependent lung adenocarcinoma independent of its catalytic activity (2020) (2)
Comparative Proteomic Analysis of Barrett's Metaplasia and Esophageal Adenocarcinoma Using 2-D Liquid Mass Mapping (2007) (2)
Signatures of drug sensitivity in non-small cell lung cancer. (2011) (2)
Exisulind and CP 248 induce growth inhibition and apoptosis in human esophageal adenocarcinoma and squamous carcinoma cells (2003) (2)
Imaging , Diagnosis , Prognosis CYP 24 A 1 Is an Independent Prognostic Marker of Survival in Patients with Lung Adenocarcinoma (2011) (2)
Sensing cellular function and molecular activity in vivo using fluorescence lifetime imaging microscopy (FLIM) (2005) (2)
Abstract 4147: Ratio of miR-146b/miR-191 in serum predicts prognosis in surgically resected lung squamous cell carcinomas (2012) (2)
Re-identification of Affymetrix HG-U133 probe sequences using BLAST alignment and its application to distinguishing lung cancer from normal lung expression profiles (2006) (1)
Abstract 830: Insulin-like growth factor binding protein-2 and chemosensitivity in esophageal adenocarcinoma (2012) (1)
Erratum: Comparative genomics of esophageal adenocarcinoma and squamous cell carcinoma (Annals of Thoracic Surgery (2012) 93 (11016)) (2012) (1)
Abstract 3124: Smoking effects onCYP24A1in lung adenocarcinoma: Epigenetic changes by smoking (2012) (1)
MicroRNA prognostic signature in malignant pleural mesothelioma. (2015) (1)
Human Cancer Biology Integrative Genomics Identi fi ed RFC 3 As an Ampli fi ed Candidate Oncogene in Esophageal Adenocarcinoma (2012) (1)
Abstract C141: KRAS G12C mutation is prognostic of poor outcome in resected lung adenocarcinomas and predictive of poor response to MEK inhibition in vitro. (2013) (1)
Abstract 3879: Osteopontin (SPP1/OPN) alternative splice variants and metastatic potential in esophageal adenocarcinoma. (2013) (1)
UBCH5 Family Members Differentially Impact Stabilization of Mutant p53 via RNF128 Iso1 During Barrett’s Progression to Esophageal Adenocarcinoma (2021) (1)
Abstract 3075:Ex-vivoexpansion of circulating tumor cells in early lung cancer using a microfluidic model (2014) (1)
P1.05-001 Creation and Early Validation of Prognostic miRNA Signatures for Squamous Cell Lung Carcinoma by the SPECS Lung Consortium: Topic: Translational Research and Biomarkers (2017) (1)
Functional gastrin receptors are present on adenocarcinoma cells of esophageal origin (2002) (1)
Abstract 5436: Identification of early lung cancer miRNA biomarkers using qRT-PCR and novel label-free nanoarray technology (2017) (1)
FAM83A antisense RNA 1 (FAM83A-AS1) silencing impairs cell proliferation and induces autophagy via MET-AMPKɑ signaling in lung adenocarcinoma (2022) (1)
Short Communication Organ-Specific Molecular Classification of Primary Lung, Colon, and Ovarian Adenocarcinomas Using Gene Expression Profiles (2001) (1)
Expression profiles associated with disease progression in non-small cell lung cancer. (2010) (1)
Association of Vitamin D and Parathyroid Hormone With Barrett’s Esophagus (2019) (1)
Imaging , Diagnosis , Prognosis Stromal LRP 1 in Lung Adenocarcinoma Predicts Clinical Outcome (2011) (1)
Supplementary Material 10 (2014) (1)
Specific and sensitive detection of BRAF and KRAS mutations in clinical samples. (2012) (1)
137 Peptide Selection for ERBB2 Molecular Imaging in Esophageal Adenocarcinoma (2012) (1)
Expression of the c-mf Protooncogene, 7-Glutamyltranspeptidase, and Gap Junction Protein in Rat Liver Neoplasms1 (2006) (1)
Principles of Palliative/Best Supportive Care (2014) (1)
Chk1 Protein Expression Indicates Sensitivity to Chk1 Inhibition by Antimetabolite Chemotherapy in Non-Small Cell Lung Cancer (2013) (1)
Characterizing isoform switching events in esophageal adenocarcinoma (2022) (1)
Identification and Characterization of a 19 q 12 Amplicon in Esophageal Adenocarcinomas Reveals Cyclin E as the Best Candidate Gene for this Amplicon 1 (2000) (1)
Correction to "Identification of Tumor Specific Peptide as EpCAM Ligand and Its Potential Diagnostic and Therapeutic Clinical Application". (2019) (0)
Abstract 1494: MicroRNAs encoded at the 14q32 cluster are associated with poor outcome in lung adenocarcinoma (2014) (0)
Abstract 2214: An integrative approach to reveal driver gene fusions from paired end sequencing data in cancer (2010) (0)
Induction of an aggressive phenotype and poor survival in early-stage lung adenocarcinoma and epigenetic inactivation of microRNA-34b/c. (2013) (0)
T1154 Role of Homologous Recombination in Telomere Maintenance and Evidence of ALT Pathway in Barrett's Adenocarcinoma Cells (2010) (0)
Inhibition of Ctgf Decreases Matrigel Invasion in Esophageal Adenocarcinoma (2013) (0)
W1953 Effect of a Novel Telomerase Inhibitor, Grn163l, On Growth of Barrett's Esophageal Adenocarcinoma Cells In Vitro and In Vivo (2008) (0)
Running Title: CYP24A1 Prognostic Marker in Lung Adenocarcinoma (2010) (0)
Fluorescence Lifetime Imaging Microscopy Detects Altered Metabolic Function in Living Human Cancer Cell Models (2006) (0)
Neoplasms-Glutamyltranspeptidase , and Gap Junction Protein in Rat Liver γ Protooncogene , raf Expression of the c-Updated Version (2006) (0)
Sturm Peptide : First-inHuman Results Targeted Imaging of Esophageal Neoplasia with a Fluorescently Labeled (2013) (0)
DualTyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-IReceptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma In vitro and In vivo (2008) (0)
Abstract LB-132: Critical prognostic genes for stage I lung cancer are identified from normal growth factor-regulated gene network by overcoming cancer heterogeneity (2010) (0)
Expression of the cmf Protooncogene , 7-Glutamyltranspeptidase , and Gap Junction Protein in Rat Liver Neoplasms 1 (2006) (0)
FAM83A-AS1 Promotes Tumor Progression Through MET Signaling in Lung Adenocarcinoma (2021) (0)
CSE1L silencing impairs tumor progression via MET/STAT3/PD-L1 signaling in lung cancer. (2021) (0)
W1979 Telomerase Activity and Telomere Length in Lcm Purified Barrett's Esophageal Adenocarcinoma Cells (2008) (0)
Abstract 279: Cranberry proanthocyanidins mitigate reflux-induced transporter dysregulation in esophageal adenocarcinoma (2018) (0)
Integrated Genomic Analysis of Esophageal Adenocarcinoma Identifies DNA Copy Number Changes and Related Gene Expression Alterations That are Associated With Survival (2012) (0)
173. Impact of Sulforaphane, Alone or in Combination with Paclitaxel, on Cell Growth, Genome-Wide Expression Profile, and Genomic Integrity, in Barrett's Adenocarcinoma Cells (2009) (0)
W1954 Sulforaphane, An Antioxidant Derived from Broccoli, Induces Apoptotic Cell Death in Barrett's Esophageal Adenocarcinoma Cells (2008) (0)
MTP12-01: Genomics and proteomics in lung cancer (2007) (0)
Abstract 496: Notch pathway activity identifies functional lung cancer stem cells and correlates with worse survival in patients with lung adenocarcinoma (2011) (0)
Abstract LB-410: Targeted resequencing of genes frequently mutated in esophageal adenocarcinoma using highly multiplexed Ion Torrent AmpliSeqTM technology and semiconductor sequencing (2012) (0)
Development and Validation of a Scalable Next-Generation Sequencing System for Assessing Relevant Somatic Variants in (2015) (0)
Plenary Symposia (2018) (0)
Response to Translating Cancer Complexity to Clinical Decisions (2011) (0)
Comprehensivegenomiccharacterization of squamous cell lung cancers (2012) (0)
Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas using two-dimensional genomic scanning and amplification mapping of sequence tagged sites (2001) (0)
Q18E mutation of Op18 detected in a gastric cardia tumor inhibits cell differentiation (1998) (0)
Abstract 3071: Epigenetic repression of miR-217 contributes to tobacco-induced esophageal carcinogenesis. (2013) (0)
Evaluation of CYP24A1 mRNA expression as a prognostic marker and predictor of calcitriol activity in lung adenocarcinoma. (2010) (0)
P1.04-23 Expression of Emerging Immunotherapy Targets in Early-Stage Squamous Lung Carcinoma (2018) (0)
invasion of lung adenocarcinoma isoform expression contributes to metastatic Tks 5 Differential Material Supplemental (2013) (0)
247PVALIDATION OF A SERUM 4-MICRORNA SIGNATURE FOR LUNG CANCER DETECTION. (2014) (0)
Plenary Symposia (2020) (0)
1559PA NOVEL PROGNOSTIC MICRORNA SIGNATURE IN MALIGNANT PLEURAL MESOTHELIOMA. (2014) (0)
Abstract 5589: Molecular signatures of in vitro drug response in lung cancer. (2013) (0)
Abstract 4137: Identification of diagnostic and prognostic miRNAs in lung cancer tissue and serum (2012) (0)
Telomerase as a therapeutic target for Barrett's-associated esophageal adenocarcinoma (2003) (0)
Localization of Specific [ 3 H ] Dexamethasone Binding in Urethan-induced Mouse Lung Tumors 1 (2006) (0)
Sucrase-Isomaltase Gene Expression and Adenocarcinoma (1993) (0)
Overexpression of LINC00152 correlates with poor patient survival and knockdown impairs cell proliferation in lung cancer (2017) (0)
OA13.01 SPECS2 Lung Cancer Consortium Prospective Multicenter Validation of Prognostic Signature for Early Stage Squamous Lung Cancer (2019) (0)
P1.05-027 Novel Prognostic Gene Expression Signatures for Squamous Cell Lung Carcinoma: A Study by the SPECS Lung Consortium: Topic: Translational Research and Biomarkers (2017) (0)
Abstract 2863: Long non-coding RNALINC00152plays an oncogenic role via targeting MET, STAT3 signaling in esophagus adenocarcinoma (2019) (0)
Adenocarcinoma Cells and Induces Apoptosis in Human Esophageal Selective Inhibition of Cyclooxygenase-2 Suppresses Growth Updated (2000) (0)
Identification of Genomic Regions Associated with Susceptibility to Barrett’s Esophagus and Esophageal Adenocarcinoma in African Americans: The Cross Betrnet Admixture Study (2017) (0)
Abstract LB-99: EGF receptor tyrosine kinase defines critical prognostic genes of stage IA lung adenocarcinoma (2012) (0)
Gene profiling of lung cancers with EGFR mutations (2005) (0)
Abstract IA6: Gene fusions in lung cancer (2012) (0)
Abstract 3573: Identification and functional characterization of prognostic long non coding RNA LADDER in lung cancer (2019) (0)
Autoradiographic demonstration of specific binding and nuclear localization of 3h-dexamethasone during normal and neoplastic lung development. Abstr. (1983) (0)
Abstract 370: Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model (2015) (0)
Tu1077 Association of Proton Pump Inhibitor Use With Hyperparathyroidism (2016) (0)
Abstract 1425: Significance of Dickkopf-3 overexpression in the pathogenesis of esophageal adenocarcinoma (2011) (0)
Abstract 5741: Characterizing isoform switching events in esophageal adenocarcinoma (2022) (0)
Abstract 4440: The functional role of insulin-like growth factor binding protein-2 in esophageal adenocarcinoma chemoresistance (2015) (0)
Abstract 4115: Prediction of drug sensitivity based on correlation of molecular and genetic signatures between lung tumor cell lines and tumor tissue samples from NSCLC cancer patients (2011) (0)
Antitumor role of 2-methoxyestradiol in Barrett’s adenocarcinoma (2005) (0)
Associations of Vitamin D Deficiency and Hyperparathyroidism with Gastroesophageal Reflux Disease and Its Sequelae: 453 (2016) (0)
Abstract LB-52: Integrative protein and transcriptomic analysis identified an EMT-associated secretory phenotype that correlates with metastasis and predicts survival in lung adenocarcinoma patients (2011) (0)
Integrated genomic characterization of oesophageal carcinoma (2017) (0)
T1153 PI 3-Kinase Inhibitor (Wortmannin) Inhibits DNA Recombination, Genomic Instability, and Growth of Barrett's Adenocarcinoma Cells (2010) (0)
Oncogenesis and Colon Exhibit Distinct Patterns of Genome Instability and Gastrointestinal Adenocarcinomas of the Esophagus, Stomach, (2012) (0)
Abstract 1581: A study of pulmonary and peripheral vein blood as sources of circulating tumor cells in early lung cancer (2015) (0)
Abstract B19: Critical prognostic genes for stage I lung adenocarcinoma are identified from normal growth factor- signaling system by overcoming cancer heterogeneity (2010) (0)
Using second harmonic generation to predict patient outcome in solid tumors (2015) (0)
Abstract 1418: Proanthocyanidins enhance chemotherapy-induced esophageal adenocarcinoma cell death (2021) (0)
Abstract 3444:LINC00152regulates cell proliferation via p38 signaling and overexpression predicts poor patient survival in lung cancer (2017) (0)
CircSMARCA5 silencing impairs cell proliferation and invasion via the miR-17-3p-EGFR signaling in lung adenocarcinoma. (2023) (0)
MA 13.02 Comprehensive Genetic Analysis Related to PD-L1 Expression in Early-stage Lung Squamous Cell Carcinoma (2017) (0)
T1176 Role of Recombinase (RAD51) in Ongoing Genomic Instability and Proliferation in Barrett's Adenocarcinoma Cells (2010) (0)
Appropriateness of Surveillance Interval in Non-Dysplastic Barrett's Esophagus (2017) (0)
Abstract C22: Differential Tks5 isoform expression contributes to metastatic invasion of lung adenocarcinoma (2013) (0)
RELEVANCE OF DNA METHYLATION TO LUNG CANCER (1999) (0)
Supplementary Material 8 (2013) (0)
OA19.01 A Standardized and Validation of Prognostic Gene Expression Signatures for Squamous Cell Lung Carcinoma by the SPECS Lung Consortium (2017) (0)
Abstract 2189: Molecular similarity of Barrett’s-associated and gastro-esophageal junction adenocarcinomas (2015) (0)
C6-06: Gene expression signatures associated with lung adenocarcinomas in female non-smoker Chinese patients (2007) (0)
Abstract B48: Regulation of mutant KRAS protein stability via SMURF2:UBCH5 complex mediated degradation of beta-TrCP1 (2014) (0)
Abstract 3379: Overexpression of CTGF is associated with chemoresistance in esophageal adenocarcinoma. (2013) (0)
Abstract 4958: Alterations in the immune microenvironment during progression from Barrett's esophagus to esophageal adenocarcinoma (2019) (0)
Abstract 2966: Amplification and activation ofGATA6sustain oncogenic lineage-survival in esophageal adenocarcinoma (2012) (0)
Update on recent prognostic markers in adenocarcinoma (2013) (0)
Imaging , Diagnosis , Prognosis Epigenetic Inactivation of microRNA-34 b / c Predicts Poor Disease-Free Survival in Early-Stage Lung Adenocarcinoma (2013) (0)
Cancer: Clinical Challenges and Opportunities (2005) (0)
Abstract 4008: MiRNA expression profiling reveals a prognostic signature in malignant pleural mesothelioma (2015) (0)
E9. Expression profiling of lung cancer and its clinical implications (2005) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With David G Beer?

David G Beer is affiliated with the following schools:

David G Beer's Academic­Influence.com Rankings

David G Beer's Degrees

Similar Degrees You Can Earn

Why Is David G Beer Influential?

David G Beer's Published Works

Published Works

What Schools Are Affiliated With David G Beer?

David G Beer's AcademicInfluence.com Rankings